Integrating HCV Care into a Opioid Treatment Program

  • Lynn E. Taylor, MD, Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, Providence, RI
  • Sophie Sprecht-Walsh, LPN, CODAC, Inc./University Medicine, Cranston, RI
  • Linda Hurley, LCDCS, CODAC, Inc., Providence, RI

 

People who inject drugs have the highest incidence/prevalence of HCV, yet a minority of HCV-infected persons with opioid addiction undergoes HCV treatment. Presenters will discuss implementation of an on-site HCV clinic at CODAC, an Opioid Treatment Program (OTP) in Providence, RI, and how on-site HCV care in OTPs overcomes barriers to treatment. HCV clinic outcome data will be presented, including cure rates and consequences of late diagnosis. We will also discuss the potential benefits for staff utilization and improved patient outcomes. Participants will learn how to replicate all or part of the initiative at their own programs.

 

final final

Share This